Literature DB >> 1102810

Carpentier's annulus and De Vegas annuloplasty. The end of the tricuspid challenge.

P Grondin, C Meere, R Limet, L Lopez-Bescos, J L Delcan, R Rivera.   

Abstract

A study evaluating the durability of two recent techniques of tricuspid annuloplasty was conducted simultaneously in two institutions. One group working in Madrid, Spain, used Carpentier's ring in 32 patients. The other in Montreal, Canada, employed De Vega's semicircular annuloplasty in 17 cases. Competence of the tricuspid valve was obtained in nearly all cases at the time of surgery and persisted after a mean follow-up of 10.3 months (Madrid) and 11.5 months (Montreal) in 77 per cent of the cases. Light (1/3) residual tricuspid insufficiency was detected in 16.5 per cent; moderate (2/3) incompetence persisted in only 6.5 per cent. The majority of the patients with residual tricuspid insufficiency had unsuccessful or incomplete repair of left-sided heart lesions.

Entities:  

Mesh:

Year:  1975        PMID: 1102810

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

Review 1.  Evidence-based surgical management of acquired tricuspid valve disease.

Authors:  Sung Ho Shinn; Hartzell V Schaff
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

2.  Echocardiographic and hemodynamic evaluation of carpentier tricuspid valvuloplasty.

Authors:  H Lambertz; M Zander; F A Flachskampf; C Minale; P Bardos; B J Messmer; S Effert
Journal:  Tex Heart Inst J       Date:  1985-12

3.  Reduced exercise capacity in patients with tricuspid regurgitation after successful mitral valve replacement for rheumatic mitral valve disease.

Authors:  P H Groves; N P Lewis; S Ikram; R Maire; R J Hall
Journal:  Br Heart J       Date:  1991-10

4.  Tricuspid valve repair with Dacron band versus DeVega or segmental annuloplasty. Hospital outcome and short term results.

Authors:  Ahmed Abdelgawad; Mona Ramadan; Heba Arafat; Ahmed Abdel Aziz
Journal:  Egypt Heart J       Date:  2017-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.